PCI:適應症和未來發展方向
...92.7%PCI:IndicationsFutureDirectionsCurrentTreatmentOptionsInCoronaryArteryDiseaseAt5,7,and10years,10.2%,15.8%,and26.4%ofpatients,respectively,assignedtoCABGhaddied,comparedwith15.8%,21.7%,and30.5%oftheirmedicallyassignedcounterparts.Riskreductions(RR)weresignificantatall3timepoints(RR=0.61,0.68,0.8...
醫源資料庫;醫學文檔庫;心血管相關中國科研應有自己的品格
...任職。三年前,他創辦了《細胞死亡與疾病》(CellDeath&Disease)並擔任主編,創辦首年該雜誌影響因子即超過5。兩年前,他在中科院上海生科院/交大醫學院健康科學研究所設立了該雜誌的中國編輯部,今年又委任國家“千人計...
醫藥經濟;生物技術;技術要聞高脂血症的一級預防和二級預防
...fromFalketal.Circulation1995;92:657–671.PCICABGEffectsofStatinsonCoronaryDisease:PrimarySecondaryPreventionStudyLDLLDLRxRRRARRNNT4S188122(-35%)34%*8.5%12CARE13998(-32%)24%*3.0%34LIPID150113(-25%)23%*3.4%30WSCPS192159(-26%)29%*2.2%46AFCAPS150113(-25%)36%^1.8%56*=NFMI/CHDmort.^=NF/FMI,UAP%**??§*Con...
醫源資料庫;醫學文檔庫;心血管相關Cross-ReactivitytoHighlyPathogenicAvianInfluenzaH5N1VirusesafterVaccinationwithNonadjuvantedandMF59-AdjuvantedInfluenzaA/Duck/Singapore/97(H5N
InfluenzaBranch,CentersforDiseaseControlandPrevention,Atlanta,GeorgiaChironVaccines,Siena,ItalyInfectiousDiseasesUnit,LeicesterRoyalInfirmary,Leicester,NationalInstituteforBiologicalStandardsandControl,PottersBarCentralPublicHealthLaboratory,HealthProtectionAgency,Colindale,UnitedKingdomAntigenicall...
醫源資料庫;在線期刊;傳染病學雜誌;2005年第191卷第8期深圳先進院光感基因技術調控神經膠質瘤增殖和凋亡研究獲進展
近日,NaturePublishingGroup(NPG)下的國際學術期刊CellDeath&Disease(2012影響因子6.044;35/184CellBiology)發表了中國科學院深圳先進技術研究院醫工所神經工程研究中心王立平及楊帆、屠潔、潘建青、羅慧莉等研究組成員的最新成果:光感...
行業資訊;臨牀快報;神經科第三節 肝移植的禁忌證和危險因素
...1155 2.PemetrisAJ,TodoS,VanThielDhetal.EvolutionofhepatitisBvirusliverdiseaseafterhepaticreplacement.Practicalandtheoreticalconsideration.AmJPathol,1990,137:667 3.O’GradyJG,WilliansR.Livertransplantationforviralhepatitis.BrMedBull.1990,46:481 4.MazzaferroV,RegaliaE,MontaltoFetal.Ris...
醫源資料庫;醫源圖書館;教材類;臨牀肝移植SerumAntibodyLevelstoActinobacillusactinomycetemcomitansPredicttheRiskforCoronaryHeartDisease
...fDentistry(P.J.P.),UniversityofHelsinki,andDepartmentofOralandMaxillofacialDiseases,HelsinkiUniversityCentralHospital,Helsinki;theResearchInstituteofPublicHealth(K.N.,R.S.,J.A.L.,J.T.S.),UniversityofKuopio;theDepartmentofHealthandFunctionalAbility(G.A.),NationalPublicHealthInstitute,Helsinki;Savonli...
醫源資料庫;在線期刊;動脈硬化血栓血管生物學雜誌;2005年第25卷第4期急性早幼粒細胞白血病患者微小殘留病的檢測與臨牀意義的研究
...和復發時間變化(略) P-S:survivalpercentoftheMRDpositiveP-F:disease-freesurvivalpercentoftheMRDpositive N-S:survivalpercentoftheMRDnegativeN-F:disease-freesurvivalpercentoftheMRDnegative 圖3MRD陽性和MRD陰性患者無病生存率和存活百分率比較(略) 2.5...
醫源資料庫;在線期刊;中華現代內科學雜誌;2006年第3卷第8期Fms-LikeTyrosineKinase3BasedImmunoprophylaxisagainstInfectionIsImprovedbyAdjuvantTreatmentwithAntiInterleukin-10Antibody
CenterforGlobalHealthandDiseasesandDepartmentofMedicine,CaseWesternReserveUniversityMedicalResearchService,LouisStokesVAMedicalCenter,Cleveland,OhioBackground.Fms-liketyrosinekinase3ligand(Flt3L)expandsdendritic-cellpopulationsinvivoandprotectsagainstmicrobialinfectioninhealthyandimmunocompromisedho...
醫源資料庫;在線期刊;傳染病學雜誌;2005年第191卷第16期FluorogenicAssayforMolecularTypingoftheLeishmaniadonovaniComplex:TaxonomicandClinicalApplications
...nd12millionpeople,and350millionpeopleareestimatedtobeatriskfordevelopingthedisease.Visceralleishmaniasis(VL),whichislethalifuntreated,isthemostseveremanifestationofthedisease,andanestimated500,000newcasesoccureachyear[1].VLis(re-)emergingandspreadingworldwide,becauseofseveralriskfactors,suchasdrugre...
醫源資料庫;在線期刊;傳染病學雜誌;2005年第191卷第16期